Cargando…

Selecting the first line treatment in non-metastatic hepatocellular carcinoma - comparing clinical practice guidelines

Primary malignancy of the liver or hepatocellular carcinoma (HCC) is unique in its presentation, disease process, and management. Unlike breast or colon cancer, the staging of HCC depends on performance status and baseline liver function along with pathological characteristics. Apart from traditiona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jogi, Soumya, Varanai, Radha, Bantu, Sravani S., Manne, Ashish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771021/ https://www.ncbi.nlm.nih.gov/pubmed/33425223 http://dx.doi.org/10.4081/oncol.2020.515

Ejemplares similares

MON-LB041 Pheochromocytoma - Illusive Myriad of Symptoms
por: Gunda, Mouna, et al.
Publicado: (2020)

Incidental Pheochromocytoma: Silent but Violent
por: Bantu, Sravani, et al.
Publicado: (2021)

ODP134 Resistant Hypocalcemia in prostate cancer with osteoblastic metastasis
por: Hariharan, Vikaash, et al.
Publicado: (2022)

The Cost Effectiveness of Donafenib Compared With Sorafenib for the First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma in China
por: Meng, Rui, et al.
Publicado: (2022)

Quality Assessment of Clinical Practice Guidelines on the Treatment of Hepatocellular Carcinoma or Metastatic Liver Cancer
por: Wang, Yingqiang, et al.
Publicado: (2014)

Cost-effectiveness analysis of sintilimab plus bevacizumab biosimilar compared with lenvatinib as the first-line treatment of unresectable or metastatic hepatocellular carcinoma
por: Zhou, Ting, et al.
Publicado: (2022)

Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma
por: Ielasi, Luca, et al.
Publicado: (2023)

Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice
por: Jain, Ankit, et al.
Publicado: (2021)

Tailored Selection of First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma of Bladder
por: Hsieh, Meng-Che, et al.
Publicado: (2016)

Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines
por: Rim, Chai Hong, et al.
Publicado: (2016)

A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk
por: Frenette, Catherine T., et al.
Publicado: (2019)

Editorial: Hepatocellular carcinoma: from personalized medicine to practical guidelines
por: El-Nakeep, Sarah, et al.
Publicado: (2023)

Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?
por: Jeepalyam, Sravan, et al.
Publicado: (2023)

Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in India
por: Gupta, Dharna, et al.
Publicado: (2023)

First-line immune checkpoint inhibitors for patients with metastatic urothelial carcinoma treated in routine clinical practice
por: Naito, Renato, et al.
Publicado: (2020)

First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma—An Update on Patient Selection and Response Evaluation
por: von Felden, Johann, et al.
Publicado: (2016)

Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma
por: Shannon, Alexander H., et al.
Publicado: (2023)

Clinical practice guidelines and real-life practice on hepatocellular carcinoma: the Hong Kong perspective
por: Hui, Rex Wan-Hin, et al.
Publicado: (2023)

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
por: Koga, Hironori, et al.
Publicado: (2023)

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
por: Xie, Diyang, et al.
Publicado: (2023)

Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
por: Goh, Myung Ji, et al.
Publicado: (2023)

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective
por: Su, Tung-Hung, et al.
Publicado: (2023)

Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap
por: Wang, Shen-Yung
Publicado: (2023)

Comparative proteomics of side population cells derived from human hepatocellular carcinoma cell lines with varying metastatic potentials
por: Liu, Hongzhi, et al.
Publicado: (2018)

First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
por: Bongiovanni, Alberto, et al.
Publicado: (2015)

2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma
Publicado: (2015)

2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Publicado: (2022)

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Publicado: (2022)

Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
por: Kim, Do Young
Publicado: (2023)

The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Publicado: (2023)

Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond
por: Feng, Maple Ye, et al.
Publicado: (2022)

Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
por: Ruff, Samantha M., et al.
Publicado: (2023)

Selecting the Best Approach for the Treatment of Multiple Non-Metastatic Hepatocellular Carcinoma
por: Cassese, Gianluca, et al.
Publicado: (2022)

Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition)
por: Chen, Jun, et al.
Publicado: (2022)

Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy
por: Tassinari, Elisa, et al.
Publicado: (2022)

Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice
por: Laquente, Berta, et al.
Publicado: (2020)

Scandinavian SSAI clinical practice guideline on choice of first‐line vasopressor for patients with acute circulatory failure
por: Møller, M. H., et al.
Publicado: (2016)

Optimal first-line and second-line treatments for metastatic renal cell carcinoma: current evidence
por: Sun, Maxine, et al.
Publicado: (2014)

Phosphoproteomic Analysis of the Highly-Metastatic Hepatocellular Carcinoma Cell Line, MHCC97-H
por: Tian, Miaomiao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_87er5o668qt311avprk8tl5ekv